Cargando…
The microbiome in inflammatory bowel diseases: from pathogenesis to therapy
Inflammatory bowel disease (IBD) has become a global disease with accelerating incidence worldwide in the 21st century while its accurate etiology remains unclear. In the past decade, gut microbiota dysbiosis has consistently been associated with IBD. Although many IBD-associated dysbiosis have not...
Autores principales: | Liu, Sheng, Zhao, Wenjing, Lan, Ping, Mou, Xiangyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Higher Education Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106558/ https://www.ncbi.nlm.nih.gov/pubmed/32601832 http://dx.doi.org/10.1007/s13238-020-00745-3 |
Ejemplares similares
-
The Role of IL-23 in the Pathogenesis and Therapy of Inflammatory Bowel Disease
por: Korta, Aleksandra, et al.
Publicado: (2023) -
Immunological pathogenesis of inflammatory bowel disease
por: Lee, Seung Hoon, et al.
Publicado: (2018) -
Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment
por: Fragoulis, George E, et al.
Publicado: (2019) -
Microbiome, Metabolome and Inflammatory Bowel Disease
por: Ahmed, Ishfaq, et al.
Publicado: (2016) -
Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies
por: Kim, Duk Hwan, et al.
Publicado: (2017)